kresmion.
Pull a receipt

Tiziana Life Sciences Ltd (TLSA)

Sector
Healthcare
Industry
Biotechnology
Last price
$0.69
As of

Kresmion compiles this page from TLSA's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

Tiziana Life Sciences Ltd (TLSA): 2 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 6-K filed 2026-11-05.

As of . Source: SEC EDGAR filings for TLSA. Method and limitations.

COMPANY DOSSIER

See the full TLSA dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for TLSA on one page. Preview it with sample data, then open it live with a free account.

Preview the TLSA dossier

Active events for TLSA

FREE, NO ACCOUNT

Every event on TLSA, as it fires

New filings, 13F moves and cross asset events on TLSA land in the record first.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

TLSA positions held by the managers we follow (2026Q2)

What the managers we follow bought and sold in Q2 2026

Manager / securityMarket value% of reported value
CITADEL ADVISORS LLC FundCUSIP G88912103 · 2026Q2$103K0.00%
RENAISSANCE TECHNOLOGIES LLC FundCUSIP G88912103 · 2026Q2$17K0.00%

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, TLSA

Going concern statement

TLSA's 20-F filed May 1, 2026 states:

These conditions raise substantial doubt about the Group's ability to continue as a going concern.

Read the 20-F on SEC EDGAR Every company with a going concern statement

More data on TLSA

Related tickers

Cite this data

Kresmion counts the managers it follows that reported a non-option position in TLSA on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on TLSA in the last 180 days.

Upstream: SEC EDGAR filings for TLSA

Kresmion, "Tiziana Life Sciences Ltd (TLSA) institutional holdings and SEC filings", data as of 2026-11-05, https://kresmion.com/research/TLSA. Upstream data: SEC EDGAR filings for TLSA.

Link to this data (HTML):

<a href="https://kresmion.com/research/TLSA">Tiziana Life Sciences Ltd (TLSA) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow TLSA on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to TLSA for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the TLSA dossier
Share

The TLSA intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.